Leptin concentration in relation to obesity

Leptin concentration in relation to obesity. In fact, Leptin concentrations adjust in response to obesity and contribute to insulin resistance
Leptin concentration in relation to obesity: Insulin resistance
Leptin regulates energy metabolism and balance in conjunction with the brain’s hypothalamus. Leptin is currently being touted as having cardio-protective benefits among its others roles in metabolism. Leptin concentrations adjust in response to obesity and contribute to insulin resistance. Besides that, doctor Dalal Akoury MD, President, and founder of AWAREmed health and wellness resource center register that, the changes in leptin concentration have also been associated with the risk factors for coronary heart disease. In the same way, increased resistin concentrations correlate with obesity-related inflammation and may be associated with the initiation and progression of atherosclerotic lesions. Resistins also promotes insulin resistance, although the actual mechanism is still not very clear.
Insulin resistance due to adipokines dysfunction is further influenced by free fatty acids liberated directly into the liver from the visceral fat tissue. Visceral fat releases chemicals and fatty acids into the portal system where they act on the connecting organs. The portal circulation system is a specialized network of blood vessels that connect the visceral organs to the liver. The excess fat in the portal circulation has detrimental effects on insulin action, which is worsened by sympathetic hyperactivity in response to obesity. Sympathetic hyperactivity causes heightened lypolytic action resulting in excess free fatty acids in the blood. These actions combined with beta cell hypersecretion and reduced insulin clearance resulting in hyperinsulemia, lead to early stage diabetes.
Leptin concentration in relation to obesity: Interleukin-6 (IL-6)
Interleukin-6 (IL-6) is possibly another factor associated with inflammatory detriment within the portal system. High levels of IL-6 are a marker for inflammation and vascular pathology. Obese subjects demonstrated a 50% greater portal vein IL-6 concentration, demonstrating, again, the profound effect visceral fat has on pathogenic indicators. Portal vein IL-6 correlates with systemic C-reactive protein concentrations. And remember that the C-reactive protein is associated with cardio and peripheral vascular disease. C-reactive protein and oxidative stress are now presumed to interact in the early inflammatory processes of atherosclerosis. This is significant for young obese individuals. Although more research is necessary for a conclusive association, the C-reactive protein may be a new risk factor for CAD in individuals under 25 years of age.
The imbalance between increased inflammatory stimuli with a concurrent reduction in anti-inflammatory activity may be the foundation for the accelerated endothelial dysfunction and insulin resistance associated with obesity and the comorbid disorders of metabolic disease. However, more research is needed to clearly delineate the particular relationships, though it seems evident that the low-grade inflammation caused by obesity and visceral adiposity lead to the premature development of the disease. This, more so than ever before, identifies the importance of weight management during the developmental years and ongoing efforts to control weight throughout one’s lifespan.
Finally, for current obese people, there is still plenty of hope. Weight loss is related to the reduction of oxidative stress and inflammation, and these beneficial effects are likely to translate into the reduction of cardiovascular risk in obese individuals. Likewise, exercise and dietary management, along with pharmacologic intervention can lead to the atherosclerotic reversal in the earlier stages of CAD. Individuals with central adiposity, poor blood lipid profiles, hypertension, or insulin resistance should seek immediate professional assistance to prevent further health detriment by scheduling an appointment with AWAREmed health center now.
Leptin concentration in relation to obesity: Insulin resistance
http://www.integrativeaddictionconference.com/wp-admin

Currently, regenerative medicine is on focus with hopes that it can be used in treatment of cardiovascular diseases. The circulating endothelial progenitor cells have been shown to possess an ability to form mature endothelial cells that can be useful in the process of vascular repair as well as neoangiogenesis. In preclinical studies, it has been shown that the circulating endothelial progenitor cells (EPCs) have the potency for cardiovascular regeneration. With this said, it is god to admit that there is still a lot needed to be done in this area to show the effectiveness of the regenerative activities of these EPCs. Here we look at how the EPCs relate to cardiovascular diseases.
To show the relationship between heart failure and the number of circulating EPCs, Valgimigli M and his counterparts tested the level of EPCs in patients suffering from heart failure and they discovered that EPC mobilization occurred in heart failure and showed a biphasic response, with elevation in early stages while depression in the advanced stages. The increased EPCs was shown as a replication of a functional bone marrow response to diffuse and severe endothelial damage during the early stages of heart failure but an additional and significant increase of tumor necrosis factor (

















